Corbus Pharmaceuticals Holdings, Inc. - Common Stock — Quarterly Financial Statistics (NASDAQ:CRBP) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -16.42 M-16.6 M-15.55 M-15.92 M-25.57 M -73.64 M Cash from investing activities 18.12 M17.74 M19.64 M-57.15 M22.45 M 2.69 M Cash from financing activities 002.85 M74.58 M— — Free cash flow -16.42 M-16.6 M-15.55 M-15.92 M-25.57 M -73.64 M

News

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Key Insights from HNSCC KOL Event Transcript

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at ASCO Transcript

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Discusses Clinical Data Update From Phase 1/2 Study of CRB-701 Presented at ASCO - Slideshow (NASDAQ:CRBP) 2026-05-26

How Much Upside is Left in Corbus Pharmaceuticals (CRBP)? Wall Street Analysts Think 318.33%

Corbus Pharmaceuticals stock rises after promising obesity drug safety data

Corbus reports positive phase 1 results for obesity drug CRB-913

Corbus to release phase 1a study results for obesity drug CRB-913

Corbus Pharmaceuticals: Data Update, Fundraising Do Not Diminish The Thesis

Corbus Pharmaceuticals: Downgrade To Hold Due To Narrow Focus Window (NASDAQ:CRBP)

Corbus Pharmaceuticals stock plunges after $75 million public offering

Roku, SPS Commerce, Newell Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Cooper-Standard Holdings (NYSE:CPS), Aptiv (NYSE:APTV)

Corbus prices $75 million public offering of common stock